National Research (NRC) EPS (2010 - 2026)
National Research (NRC) EPS from Jun 30, 2010 to Mar 31, 2026. The TTM National Research (NRC) EPS is $0.40. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EPS
Quarterly EPS
National Research (NRC) EPS CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -61.57% |
| 3 Years TTM | -31.16% |
| 5 Years TTM | -21.85% |
| All Time TTM | -7.12% |
Annual EPS change of National Research (NRC)
| Year | EPS | Change |
|---|---|---|
| 2026 | $0.14 | -72.12% |
| 2025 | $0.51 | -52.27% |
| 2024 | $1.07 | -16.05% |
| 2023 | $1.28 | -0.97% |
| 2022 | $1.29 | -12.61% |
| 2021 | $1.48 | +0.68% |
| 2020 | $1.47 | +12.96% |
| 2019 | $1.30 | +7.22% |
| 2018 | $1.21 | +10.58% |
| 2017 | $1.10 | +69.40% |
| 2013 | $0.65 | -70.49% |
| 2012 | $2.19 | +27.51% |
| 2011 | $1.72 | -0.83% |
| 2010 | $1.73 | +35.52% |
| 2009 | $1.28 | N/A |
Comparison National Research (NRC) five years EPS CAGR with competitors
National Research (NRC) five years EPS CAGR is -21.84%.
| Ticker | Name | five years EPS CAGR | Upside |
|---|---|---|---|
| HQY | Healthequity Inc | 114.60% | -624.71% |
| DOCS | Doximity Inc - Class A | 26.71% | -222.29% |
| VEEV | Veeva Systems Inc - Class A | 25.33% | -215.99% |
| EVH | Evolent Health Inc - Class A | 12.23% | -156.00% |
| SOPH | SOPHiA Genetics SA | 6.46% | -129.57% |
| HSTM | Healthstream Inc | 5.05% | -123.11% |
| HCAT | Health Catalyst Inc | 4.23% | -119.39% |